Correlation Between Intech Biopharm and Mosel Vitelic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intech Biopharm and Mosel Vitelic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intech Biopharm and Mosel Vitelic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intech Biopharm and Mosel Vitelic, you can compare the effects of market volatilities on Intech Biopharm and Mosel Vitelic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intech Biopharm with a short position of Mosel Vitelic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intech Biopharm and Mosel Vitelic.

Diversification Opportunities for Intech Biopharm and Mosel Vitelic

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Intech and Mosel is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Intech Biopharm and Mosel Vitelic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosel Vitelic and Intech Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intech Biopharm are associated (or correlated) with Mosel Vitelic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosel Vitelic has no effect on the direction of Intech Biopharm i.e., Intech Biopharm and Mosel Vitelic go up and down completely randomly.

Pair Corralation between Intech Biopharm and Mosel Vitelic

Assuming the 90 days trading horizon Intech Biopharm is expected to under-perform the Mosel Vitelic. But the stock apears to be less risky and, when comparing its historical volatility, Intech Biopharm is 1.84 times less risky than Mosel Vitelic. The stock trades about -0.14 of its potential returns per unit of risk. The Mosel Vitelic is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  3,260  in Mosel Vitelic on September 1, 2024 and sell it today you would earn a total of  190.00  from holding Mosel Vitelic or generate 5.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Intech Biopharm  vs.  Mosel Vitelic

 Performance 
       Timeline  
Intech Biopharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intech Biopharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Mosel Vitelic 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Mosel Vitelic are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Mosel Vitelic may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Intech Biopharm and Mosel Vitelic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intech Biopharm and Mosel Vitelic

The main advantage of trading using opposite Intech Biopharm and Mosel Vitelic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intech Biopharm position performs unexpectedly, Mosel Vitelic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosel Vitelic will offset losses from the drop in Mosel Vitelic's long position.
The idea behind Intech Biopharm and Mosel Vitelic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data